Evaluation of The Triage System for Emergency Drugs-of-Abuse Testing in Urine

Journal of Analytical Toxicology

Volumn 17, Issue 4, 1993, Pages 241-245

  Wu, Alan H B ^a   Wong, Shan S ^a   Johnson, Kent G ^b   Callies, James ^c   Shu, D X ^c   Dunn, Willard E ^d   Wong, Steven H Y ^d  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b MEMORIAL HERMANN HOSPITAL   (United States)

^c Nichols Institute for Substance Abuse Testing ^*  (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE DERIVATIVE; BARBITURIC ACID DERIVATIVE; BENZOYLECGONINE; OPIATE DERIVATIVE; PHENCYCLIDINE; PHENOBARBITAL; TETRAHYDROCANNABINOL;

ACCURACY; ARTICLE; CONTROLLED STUDY; DRUG ABUSE; DRUG SCREENING; DRUG URINE LEVEL; EMERGENCY HEALTH SERVICE; ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE; GAS CHROMATOGRAPHY; HUMAN; MASS SPECTROMETRY; PRIORITY JOURNAL;

COMPARATIVE STUDY; EMERGENCIES; ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE; EVALUATION STUDIES; HUMAN; IMMUNOASSAY; MASS FRAGMENTOGRAPHY; REPRODUCIBILITY OF RESULTS; STREET DRUGS; SUBSTANCE ABUSE DETECTION;

EID: 0027291114     PISSN: 01464760     EISSN: 19452403     Source Type: Journal    
DOI: 10.1093/jat/17.4.241     Document Type: Article

References (11)

1. M. Oellerich. Enzyme immunoassay in clinical chemistry. Present status and trends. J. Clin. Chem. Clin. Biochem. 18:197-208 (1980).
2. G. Tso, A.H.B. Wu, and S.S. Wong. Screening for drugs-of-abuse by Syya II reagents. Res. Comm. Substance Abuse 13: 256-68 (1992).
3. K.J. Jones. Evaluation of the Abbott ADx analyzer in the traditional and non-traditional markets [Abstract]. Clin. Chem. 35: 1174 (1989).
4. A.J. McBay. Drug-analysis technology: Pitfalls and problems of drug testing. Clin. Chem. 33: 33-40B (1987).
5. G. Anderson, A.J. Vekich, and M. Scott. Evaluation of a rapid qualitative EIA test for drugs of abuse [Abstract], Clin. Chem. 36: 1021 (1990).
6. K.F. Buechler, S. Moi, and B. Noar. Simultaneous detection of seven drugs of abuse by the Triage panel for drugs of abuse. Clin. Chem. 38: 1678-84 (1992).
7. Department of Health and Human Services. Mandatory guidelines for Federal workplace drug testing programs; Final guideline notice. Fed. Reg. 53:11969-89 (1989).
8. A.S. Christophersen. Tetrahydrocannabinol stability in whole blood: Plastic versus glass containers. J. Anal. Toxicol. 10: 129-31 (1966).
9. A.H.B. Wu, T.A. Onigbinde, S.S. Wong, and K.G. Johnson. Evaluation of full-scanning GC-ion trap MS analysis of NIDA drugs-of-abuse testing in urine. J. Anal. Toxicol. 16:202-206 (1992).
10. R.L. Fitzgerald, J.M. Ramos, S.C. Bogema, and A. Poklis. Resolution of methamphetamine stereoisomers in urine drug testing: Urinary excretion of R(-)methamphetamine following use of nasal inhalers. J. Anal. Toxicol. 12: 255-59 (1988).
11. M.D. Solomon and J.A. Wright. False-positive for (+)-metham-phetamine. Clin. Chem. 23: 1584-87 (1977).